At 54, I've made peace with the odd bulge, the odd ripple of flesh. I don't want to lose anything. What I want is more energy ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...

For Mercè Boada, medical director of the Ace Alzheimer Center Barcelona, despite the safety and cost issues of lecanemab, ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

While the West Virginia Public Employees Insurance Agency Finance Board is on the road for public meetings getting feedback ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...